202 related articles for article (PubMed ID: 18034844)
1. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications.
Tousoulis D; Tsarpalis K; Cokkinos D; Stefanadis C
Diabetes Obes Metab; 2008 Sep; 10(10):834-42. PubMed ID: 18034844
[TBL] [Abstract][Full Text] [Related]
2. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
3. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
5. The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.
Vijayaraghavan K; Deedwania PC
Cardiol Clin; 2005 May; 23(2):165-83. PubMed ID: 15694745
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and the endothelium.
Hsueh WA; Lyon CJ; Quiñones MJ
Am J Med; 2004 Jul; 117(2):109-17. PubMed ID: 15234647
[TBL] [Abstract][Full Text] [Related]
7. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
9. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes.
Wycherley TP; Brinkworth GD; Noakes M; Buckley JD; Clifton PM
Diabetes Obes Metab; 2008 Nov; 10(11):1062-73. PubMed ID: 18435772
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
11. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
Glueck CJ; Goldenberg N; Sieve L; Wang P
Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
[TBL] [Abstract][Full Text] [Related]
12. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide.
Newsholme P; Homem De Bittencourt PI; O' Hagan C; De Vito G; Murphy C; Krause MS
Clin Sci (Lond); 2009 Nov; 118(5):341-9. PubMed ID: 19922417
[TBL] [Abstract][Full Text] [Related]
13. Management of the metabolic syndrome.
Grant RW; Meigs JB
Panminerva Med; 2005 Dec; 47(4):219-28. PubMed ID: 16489321
[TBL] [Abstract][Full Text] [Related]
14. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
15. Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.
Burgert TS; Duran EJ; Goldberg-Gell R; Dziura J; Yeckel CW; Katz S; Tamborlane WV; Caprio S
Pediatr Diabetes; 2008 Dec; 9(6):567-76. PubMed ID: 18761646
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
Dandona P; Ghanim H; Chaudhuri A; Mohanty P
J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
[TBL] [Abstract][Full Text] [Related]
17. Review article: diabetes and atherosclerosis--running on a common road.
Federici M; Lauro R
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of vascular dysfunctionin insulin resistance.
Busija DW; Miller AW; Katakam P; Simandle S; Erdös B
Curr Opin Investig Drugs; 2004 Sep; 5(9):929-35. PubMed ID: 15503646
[TBL] [Abstract][Full Text] [Related]
19. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
Cho LW; Kilpatrick ES; Keevil BG; Coady AM; Atkin SL
Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
[TBL] [Abstract][Full Text] [Related]
20. Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents.
Home PD; Pacini G
Diabetes Obes Metab; 2008 Sep; 10(9):699-718. PubMed ID: 17825080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]